Page last updated: 2024-10-30

meclofenamic acid and Lymphoma, Non-Hodgkin

meclofenamic acid has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambrus, JL1
Ambrus, CM1
Halpern, J1
Gastpar, H1

Other Studies

1 other study available for meclofenamic acid and Lymphoma, Non-Hodgkin

ArticleYear
Effect of second tumors and of prostaglandin-leukotriene inhibitors on radiation therapy of transplanted rodent tumors.
    Journal of medicine, 1984, Volume: 15, Issue:2

    Topics: Animals; Autacoids; Dinoprostone; Lymphoma, Non-Hodgkin; Meclofenamic Acid; Mice; Mice, Inbred C3H;

1984